Investigational Site Number: 6160004

Lublin, Lublin Voivodeship 20-607

1 studies enrolling now · 3 studies all time

What they study most

Cutaneous Lupus Erythematosus, Dermatitis Atopic

Studies at this site

• A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials — Enrolling by invitation
• Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus — Completed